Healio

Mild to moderate asthma may include high FeNO, eosinophil counts

Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...
Healio

Multifocal IOLs significantly reduce spectacle use in mild to moderate glaucoma

Please provide your email address to receive an email when new articles are posted on . Significantly more patients with multifocal IOLs were spectacle-free for near tasks than those with monofocal ...
Medscape

A Better, Lower-Cost Option for Mild to Moderate Depression?

A mindfulness-based cognitive therapy self-help (MBCT-SH) intervention in which patients were supported by a trained practitioner led to better clinical outcomes at lower cost than ...
Medscape

Most COVID-19 Drugs Fall Short, Meta-Analysis Confirms

Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...
Monthly Prescribing Reference

Zunveyl Approved for Mild to Moderate Alzheimer Disease

Zunveyl was designed to reduce the gastrointestinal side effects observed with galantamine. The Food and Drug Administration (FDA) has approved Zunveyl (benzgalantamine) for the treatment of mild to ...
Monthly Prescribing Reference

Fasting-Mimicking Diet Beneficial in Mild-to-Moderate Crohn Disease

More patients in FMD group met primary outcome of clinical response and prespecified secondary outcome of clinical remission. HealthDay News — A fasting-mimicking diet (FMD) is beneficial for ...
Nasdaq

Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today ...